Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Lenvima 4mg Capsules:
Lenvima 4mg Capsule is an oral receptor tyrosine kinase inhibitor prescribed for the treatment of thyroid cancer.
Mechanism of Action of Lenvima 4mg Capsules:
Lenvima 4mg Capsule acts as a tyrosine kinase inhibitor, blocking the oxygen and nutrient supply to cancer cells, thereby halting their growth.
Uses of Lenvima 4mg Capsules:
Thyroid cancer
Dosage and Administration:
Lenvima 4mg Capsule can be taken with or without food, preferably at the same time each day to maximize its benefits. The dosage and frequency of administration will be determined by your physician based on the specific condition being treated. It is crucial to adhere to your doctor's instructions precisely to avoid potential side effects. Do not discontinue the medication unless instructed by your healthcare provider.
Benefits of Lenvima 4mg Capsules:
In Thyroid Cancer:
Lenvima 4mg Capsule limits the oxygen supply to cancer cells, inhibiting their growth and further spread. It is a potent and highly toxic medication, so it's important to discuss the risks and benefits with your primary care physician. It is advisable to refrain from drinking alcohol or smoking during this treatment and to stay hydrated by drinking plenty of water.
Lenvima 4mg Capsule is an important treatment option for thyroid cancer, exerting its effects by targeting cancer cells and inhibiting their growth and proliferation.